Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey
dc.contributor.author | Onec, Birgul | |
dc.contributor.author | Ali, Ridvan | |
dc.contributor.author | Ustun, Celalettin | |
dc.contributor.author | Ilhan, Osman | |
dc.contributor.author | Saydam, Guray | |
dc.contributor.author | Sahin, Fahri | |
dc.contributor.author | Sonmez, Mehmet | |
dc.contributor.author | Guler, Nil | |
dc.contributor.author | Hacioglu, Sibel Kabukcu | |
dc.contributor.author | KEKLİK KARADAĞ, FATMA | |
dc.contributor.author | Yenerel, Mustafa Nuri | |
dc.contributor.author | Mehmet, Yilmaz | |
dc.contributor.author | Teke, Hava Uskudar | |
dc.contributor.author | Ozkocaman, Vildan | |
dc.contributor.author | Tuglular, Tulin | |
dc.contributor.author | Erdem, Fuat | |
dc.contributor.author | Unal, Ali | |
dc.contributor.author | Ayyildiz, Orhan | |
dc.contributor.author | Ozet, Gulsum | |
dc.contributor.author | Ozkan, Melda | |
dc.contributor.author | Kaya, Emin | |
dc.contributor.author | Ayer, Mesut | |
dc.contributor.author | Salim, Ozan | |
dc.contributor.author | Guvenc, Birol | |
dc.contributor.author | Ozdogu, Hakan | |
dc.contributor.author | Mehtap, Ozgur | |
dc.contributor.author | Aydogdu, Ismet | |
dc.contributor.author | Bektas, Ozlen | |
dc.contributor.author | Toprak, Selami Kocak | |
dc.contributor.author | Kaynar, Lale | |
dc.contributor.author | Yagci, Munci | |
dc.contributor.author | Aksu, Salih | |
dc.contributor.author | Tombak, Anil | |
dc.contributor.author | Karakus, Volkan | |
dc.contributor.author | Yavasoglu, Irfan | |
dc.contributor.author | Ozcan, Mehmet Ali | |
dc.contributor.author | Undar, Levent | |
dc.date.accessioned | 2021-03-04T12:49:51Z | |
dc.date.available | 2021-03-04T12:49:51Z | |
dc.identifier.citation | KEKLİK KARADAĞ F., Yenerel M. N. , Mehmet Y., Teke H. U. , Ozkocaman V., Tuglular T., Erdem F., Unal A., Ayyildiz O., Ozet G., et al., "Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey", 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_794ebc2c-29e0-4757-ab4e-7e5be90807b8 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/83151 | |
dc.identifier.uri | https://doi.org/10.1182/blood-2019-128743 | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Hematoloji | |
dc.subject | Hematology | |
dc.subject | Health Sciences | |
dc.subject | HEMATOLOJİ | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.title | Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey | |
dc.type | Bildiri | |
dc.contributor.department | PNH Educ & Study Grp , , | |
dc.identifier.volume | 134 | |
dc.contributor.firstauthorID | 2497704 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]